A Note About COVID-19 for Patients Enrolled in our Clinical Studies | Questions About Our Medicines? Visit medinfo.roche.com

 

Roche has established a multi-lingual global hotline (Phone: +36 146 182 58 | WhatsApp/SMS: + 36 707 177 394) and email (patientcare@roche.com) for patients and healthcare providers in or from Ukraine. We will do our best to provide everyone who is in need with the appropriate information and support.

What is multiple sclerosis?

Multiple sclerosis (MS) is a disease of the central nervous system, estimated to affect 2.3 million people worldwide. It is a chronic disease in which the immune system abnormally attacks the insulation and support around the nerve cells (myelin sheath) in the brain, spinal cord and optic nerves, causing inflammation and consequent damage. MS is a leading cause of non-traumatic disability in young people, usually striking between 20 and 40 years of age. There is no cure for MS, but research continues to better understand and treat the disease.

 

Learn more about multiple sclerosis and research at Roche.

For patients in the US, learn more about multiple sclerosis and research at Genentech.

Clinical Research Explained

Information about what clinical trials and observational studies are. Understand why you might want to take part in clinical research and why diversity in clinical research is important.

Find out now